Why the study?
Do clinical and laboratory markers of hypercoagulability and endothelial damage predict venous thromboembolism after pacemaker implantation?
Do clinical and laboratory markers of hypercoagulability and endothelial damage predict venous thromboembolism after pacemaker implantation?
Clustering of classic thrombotic risk factors, rather than procedure-induced hypercoagulability or endothelial damage markers, plays a role in the pathogenesis of venous thromboembolism after pacemaker implantation.
Answers are grounded in this paper and cite their sources.
Classic risk factor clustering may inform post-pacemaker VTE assessment; leaves open predictive utility of hypercoagulability markers pending prospective studies.
Pacemaker implantation induces a transient hypercoagulable state, but its degree does not predict subsequent venous thromboembolism, and neither did the grade of endothelial damage as reflected by plasma markers. The aetiology of these lesions seems to be multifactorial, and clustering of classic thrombotic risk factors plays a role in the pathogenesis.
No takes yet. Share an insight, caveat, or question.
Korkeila et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: